Failure Mode and Effect Analysis: A Technique to Prevent the Risk of SARS-COV-2 Infectionin A Retrocession Unit

Authors

  • Esso Eric Valery Latt
  • Youssef Moutaouakkil
  • ZidaneQriouet
  • YassineAtbib
  • YasminaTadlaoui
  • Jamal Lamsaouri
  • YassirBousliman

DOI:

https://doi.org/10.37506/ijfmt.v15i3.15742

Keywords:

FMEA, hospital retrocession, risk of infection, SARS-CoV-2, COVID-19, quality, security

Abstract

Securing healthcare workers and patients against the severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) infection/transmission, require the development of new tools and methods. Several laboratories have
started recently clinical trials to develop vaccines and drugs, however these solutions require more time to
evaluate and validate them.
As an alternative and in order to stop the spread of SARS-CoV-2 infection, our objective is to implement
preventive and corrective actions to reduce the infectious/transmission risk of SARS-COV-2 during hospital
retrocession, using the failure mode effect analysis (FMEA) method. The criticality of each failure mode
was assessed by calculating the criticality index (CI). The obtained data showed 12 fault modes with a
total criticality index (CI) of 480, two acceptable risks, four significant risks and six critical risks. Ten risks
were identified as priorities (CI > 15): four related to patient reception, two related to personnel, two during
dispensation, one related to the end of dispensation and the last related to traceability. These risks were
corrected by improvement actions proposed by FMEA and then re-evaluated effectively.
This study assessed the feasibility and relevance of the use ofFMEA in the hospital retrocession dispensing
process related to the infectious/transmission risk of SARS-CoV-2.
Finally, FMEA seems to be an effective method to reduce the infectious/transmission risk of SARS-COV-2
during hospital retrocession.

Author Biographies

  • Esso Eric Valery Latt

    Resident in Clinical Pharmacy, Laboratory of Pharmacology and Toxicology, Faculty of Medicine and Pharmacy,
    Mohammed V University in Rabat, Rabat Institute, Rabat, Morocco

  • Youssef Moutaouakkil

    Specialist in ClinicalPharmacy, Laboratory
    of Pharmacology and Toxicology, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat
    Institute, Rabat, Morocco

  • ZidaneQriouet

    PhD Student, Laboratory of Pharmacology and Toxicology, Faculty of Medicine and
    Pharmacy, Mohammed V University in Rabat, Rabat Institute, Rabat, Morocco - Medical Biotechnology Center,
    Moroccan Foundation for Science, Innovation & Research (MAScIR), Rabat, Morocco

  • YassineAtbib

    Resident in Clinical Pharmacy, Laboratory of Pharmacology and Toxicology, Faculty of Medicine and Pharmacy,
    Mohammed V University in Rabat, Rabat Institute, Rabat, Morocco

  • YasminaTadlaoui

    Professor of Clinical
    Pharmacy, Pharmacy Department, Mohamed V Military Training Hospital, Rabat, Morocco

  • Jamal Lamsaouri

    Professor of
    Therapeutic Chemistry, Laboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Rabat Institute,
    University Mohamed V, Rabat-Morocco,

  • YassirBousliman

    Professor of Toxicology, Laboratory of Pharmacology-Toxicology,
    Faculty of Medicine and Pharmacy, Rabat Institute, University Mohamed V, Rabat Morocco

Downloads

Published

2021-05-17

How to Cite

Failure Mode and Effect Analysis: A Technique to Prevent the Risk of SARS-COV-2 Infectionin A Retrocession Unit. (2021). Indian Journal of Forensic Medicine & Toxicology, 15(3), 2878-2882. https://doi.org/10.37506/ijfmt.v15i3.15742